Mean ESSPRI score (dryness domain) for all groups and time points
| Control group | 95% CI | Saline group | 95% CI | Saline/TA group | 95% CI | |||||||
| Mean | SD | Lower limit | Upper limit | Mean | SD | Lower limit | Upper limit | Mean | SD | Lower limit | Upper limit | |
| T0 | 8.00 (*) | 1.13 | 7.37 | 8.63 | 6.88 (*) | 1.66 | 5.99 | 7.76 | 7.92 (§§,¶¶,***) | 1.52 | 7.16 | 8.67 |
| T1 | 7.87 (†) | 1.60 | 7.01 | 8.73 | 6.34 (†) | 1.90 | 5.33 | 7.40 | 7.50 (†††,‡ ‡‡) | 2.12 | 6.45 | 8.55 |
| T8 | 8.20 (‡, §) | 1.15 | 7.57 | 8.84 | 5.75 (‡) | 1.98 | 4.69 | 6.81 | 6.22 (§§,†††,§) | 1.92 | 5.26 | 7.18 |
| T16 | 8.53 (¶,**) | 1.19 | 7.88 | 9.19 | 6.22 (¶) | 2.10 | 5.11 | 7.33 | 6.40 (¶¶,‡‡‡,**) | 1.91 | 5.44 | 7.34 |
| T24 | 8.01 (††,‡‡) | 1.49 | 7.24 | 9.00 | 6.28 (††) | 1.83 | 5.31 | 7.25 | 6.50 (***,‡‡) | 2.26 | 5.28 | 7.72 |
Data sharing the same symbols (*, †, ‡, §, ¶, **, ††, ‡‡, §§, ¶¶, ***, †††, ‡‡‡) differ significantly (P<0.05).
ESSPRI, EULAR Sjögren’s Syndrome Patient-Reported Index; TA, triamcinolone acetonide; T0, 1 week before intervention; T1, 1 week after intervention; T8, 8 weeks after intervention; T16, 16 weeks after intervention; T24, 24 weeks after intervention.